Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
Published in Healthcare Mergers, Acquisitions and Ventures Week, December 29th, 2007
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology, said that its current non-executive Chairman of the Board, David F. Hale, has been appointed Executive Chairman, effective immediately, and will become interim Chief Executive Officer of the company, effective January 1, 2008. Kenneth M. Cohen has resigned as President and Chief Executive Officer of the company, effective December 31, 2007.
Mr. Cohen will remain as a member of the company's Board of Directors until the earlier...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 2005 Limra International "Trends in Life Insurance Ownership Among U.S. Households" report
Global Study Shows Americans Caught in Cycle of Anxiety - Abbott
Abbott and HealthReach Increase Access to Health Care for Lake County's Uninsured With Newly Expanded Free Clinic - Abbott
Similac(R) Survey Finds New Moms Want Convenient, Time-Saving Baby Products - Abviva, Inc.
Abviva Announces Letter of Intent to Acquire Prion Developmental Laboratories - AcuNetx, Inc.
AcuNetx Subsidiary Reaches Agreement That Promises to Improve Prospects - Acute Leukemia
Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
